Profile
Gene Kenyon is currently a Director at The Plaza Group Ltd. and a Managing Director at Goradia Capital LLC since 2007.
He previously worked as a Senior Vice President at Sterling Chemicals, Inc. and as a Principal at Shell Chemical Corp.
Gene Kenyon active positions
| Companies | Position | Start |
|---|---|---|
Goradia Capital LLC
Goradia Capital LLC Investment ManagersFinance Goradia Capital invests in companies located in the United States with an EBITDA of USD 5-50 million and revenues of USD 25-500 million. The firm targets companies operating in the fields of commodity chemicals, specialty chemicals, polymers and polymer formulations, bio-based chemicals & polymers and polymer recycling. It participates in growth, buyout, corporate carve-outs/spin-offs and distressed buyouts in the form of equity and debt. The firm acquires controlling interest and makes co-investments. | Private Equity Investor | 2006-12-31 |
The Plaza Group Ltd.
The Plaza Group Ltd. Wholesale DistributorsDistribution Services Distributes petrochemical solvents and chemical intermediates | Director/Board Member | - |
Former positions of Gene Kenyon
| Companies | Position | End |
|---|---|---|
Shell Chemical Corp. | Corporate Officer/Principal | - |
Sterling Chemicals, Inc.
Sterling Chemicals, Inc. Oil Refining/MarketingEnergy Minerals Produces petrochemicals | Corporate Officer/Principal | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Sterling Chemicals, Inc.
Sterling Chemicals, Inc. Oil Refining/MarketingEnergy Minerals Produces petrochemicals | Energy Minerals |
The Plaza Group Ltd.
The Plaza Group Ltd. Wholesale DistributorsDistribution Services Distributes petrochemical solvents and chemical intermediates | Distribution Services |
Shell Chemical Corp. | |
Goradia Capital LLC
Goradia Capital LLC Investment ManagersFinance Goradia Capital invests in companies located in the United States with an EBITDA of USD 5-50 million and revenues of USD 25-500 million. The firm targets companies operating in the fields of commodity chemicals, specialty chemicals, polymers and polymer formulations, bio-based chemicals & polymers and polymer recycling. It participates in growth, buyout, corporate carve-outs/spin-offs and distressed buyouts in the form of equity and debt. The firm acquires controlling interest and makes co-investments. | Finance |
- Stock Market
- Insiders
- Gene Kenyon
















